We further demonstrate that elevated expression of ZFX/UGCG alters ganglioside levels and activates epidermal growth factor receptor (EGFR)-mediated PI3K/AKT/mTOR/MAPK signaling, leading to tumor progression. The gene discussed is ZFX; the disease is neoplasm.